Alcon Management S.A. entered into an agreement to acquire BELKIN Vision Ltd. form BioLight Life Sciences Ltd. (TASE:BOLT) and others for ILS 49.1 million on May 3, 2024. Consideration in the amount of about ILS 9 million in cash and Additional consideration in the amount of up to approximately ILS 40.085 million to be paid, in periodic payments depending on compliance with the requirements through the provisions of the merger agreement in connection with the revenue targets from annual sales of Belkin products by Alcon. Belkin will become a wholly owned subsidiary of Alcon.

Completion of the merger transaction is subject to the existence of conditions precedent as is customary in merger transactions of this type, including approval Belkin's general meeting for the merger, correctness of the parties representations and receipt of the merger certificate from the Companies Registry. The merger transaction will be completed no later than 120 days from the date of signing the merger agreement, and it can be extended as is customary in agreements of this type, including with the agreement of the parties or due to a delay in receiving the merger certificate from the Companies Registry same as the merger agreement includes provisions for termination and cancellation of event controls that are accepted in agreements of this type.